Ibrutinib with rituximab for treating Waldenstrom’s macroglobulinaemia (terminated appraisal)

  • Technology appraisal
  • TA608
  • Published: 

History

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators